The impact of COVID-19 and COVID vaccination on cardiovascular outcomes

C. Macintyre,A. Moa,Zubair Akhtar,Ole Fröbert,Mallory J. Trent,T. Tan

DOI: https://doi.org/10.1093/eurheartjsupp/suac123

2023-02-01

European Heart Journal, Supplement

Abstract:Abstract COVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or pericarditis. Patients with COVID-19 may present with non-specific symptoms that have a cardiac origin. This review examines the cardiovascular complications of COVID-19 infection and the impact of COVID-19 vaccination. COVID-19 cardiovascular complications include myocardial injury, pericarditis, coagulopathy, myocardial infarction, heart failure, arrhythmias, and persistent post-acute risk of adverse cardiovascular outcomes. Diagnostic and referral pathways for non-specific symptoms, such as dyspnoea and fatigue, remain unclear. COVID-19 vaccination is cardioprotective overall but is associated with myopericarditis in young males, though at a lower rate than following SARS-CoV-2 infection. Increased awareness among primary care physicians of potential cardiovascular causes of non-specific post-COVID-19 symptoms, including in younger adults, such as fatigue, dyspnoea, and chest pain, is essential. We recommend full vaccination with scheduled booster doses, optimal management of cardiovascular risk factors, rapid treatment of COVID-19, and clear diagnostic, referral, and management pathways for patients presenting with non-specific symptoms to rule out cardiac complications.

Medicine

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

The paper primarily explores the impact of COVID-19 infection and its vaccination on cardiovascular diseases (CVD). Specifically, the paper aims to:

1. **Cardiovascular Complications**: Investigate cardiovascular complications caused by COVID-19 infection, including myocardial injury, pericarditis, thrombosis, acute coronary syndrome, etc., and analyze their mechanisms.
2. **Long-term Effects**: Assess the long-term cardiovascular effects after COVID-19 infection, especially symptoms that persist after recovery.
3. **Vaccine Efficacy**: Evaluate the effectiveness of COVID-19 vaccines in preventing cardiovascular complications, particularly in comparison to unvaccinated populations.
4. **Side Effects**: Discuss side effects such as myocarditis and pericarditis caused by mRNA vaccines and compare their incidence rates with those after natural infection.
5. **Clinical Pathways**: Propose diagnostic and management pathways for non-specific symptoms (such as fatigue and shortness of breath) to help doctors better identify potential cardiovascular complications.

Through these studies, the paper hopes to provide better guidance for clinicians to effectively manage and prevent cardiovascular diseases induced by COVID-19.